共 174 条
[1]
Mathai SC(2016)Management of interstitial lung disease associated with connective tissue disease BMJ 352 h6819-1128
[2]
Danoff SK(2016)Management of myositis-related interstitial lung disease Chest 150 1118-492
[3]
Morisset J(2017)Myositis-associated usual interstitial pneumonia has a better survival than idiopathic pulmonary fibrosis Rheumatology 56 kew426-971
[4]
Johnson C(2013)Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease J Rheumatol 40 484-105
[5]
Rich E(2009)Rituximab treatment of the anti-synthetase syndrome—a retrospective case series Rheumatology 48 968-340
[6]
Collard HR(2015)Efficacy of rituximab in refractory inflammatory myopathies associated with anti-synthetase auto-antibodies: an open-label, phase II trial PLoS One 10 99-253
[7]
Lee JS(2015)Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review Clin Rheumatol 34 335-994
[8]
Aggarwal R(2012)Interstitial lung disease outcomes by high-resolution computed tomography (HRCT) in anti-Jo1 antibody-positive polymyositis patients: a single centre study and review of the literature Autoimmun Rev 11 249-830
[9]
Cavagna L(2006)In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease Autoimmunity 39 989-325
[10]
Caporali R(2009)Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients Rheumatol Int 29 821-700